Canada markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
955.76-14.21 (-1.46%)
At close: 04:00PM EDT
957.04 +1.28 (+0.13%)
After hours: 04:44PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 106.88B
Enterprise Value 99.06B
Trailing P/E 28.64
Forward P/E 22.03
PEG Ratio (5 yr expected) 1.60
Price/Sales (ttm)8.44
Price/Book (mrq)3.96
Enterprise Value/Revenue 7.56
Enterprise Value/EBITDA 21.78

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 329.40%
S&P500 52-Week Change 325.38%
52 Week High 3998.33
52 Week Low 3684.81
50-Day Moving Average 3943.29
200-Day Moving Average 3871.21

Share Statistics

Avg Vol (3 month) 3466.71k
Avg Vol (10 day) 3538.64k
Shares Outstanding 5108.37M
Implied Shares Outstanding 6110.19M
Float 8105.49M
% Held by Insiders 11.69%
% Held by Institutions 188.99%
Shares Short (Apr 15, 2024) 41.39M
Short Ratio (Apr 15, 2024) 43.05
Short % of Float (Apr 15, 2024) 41.50%
Short % of Shares Outstanding (Apr 15, 2024) 41.26%
Shares Short (prior month Mar 15, 2024) 41.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 29.45%
Operating Margin (ttm)24.12%

Management Effectiveness

Return on Assets (ttm)7.74%
Return on Equity (ttm)15.28%

Income Statement

Revenue (ttm)13.1B
Revenue Per Share (ttm)122.57
Quarterly Revenue Growth (yoy)-0.50%
Gross Profit (ttm)N/A
EBITDA 4.42B
Net Income Avi to Common (ttm)3.86B
Diluted EPS (ttm)33.85
Quarterly Earnings Growth (yoy)-11.70%

Balance Sheet

Total Cash (mrq)10.52B
Total Cash Per Share (mrq)95.47
Total Debt (mrq)2.7B
Total Debt/Equity (mrq)10.02%
Current Ratio (mrq)5.27
Book Value Per Share (mrq)244.93

Cash Flow Statement

Operating Cash Flow (ttm)4.74B
Levered Free Cash Flow (ttm)3.03B